Medtronic plc (MDT) Guidance & Earnings Results

On 2026-09-01 Medtronic plc raised guidance: "FY27 organic revenue growth guidance raised to 7.25-7.75% from 6.75-7.25%; FY27 non-GAAP EPS guidance raised to $5.94-6.00 from…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason

MDTMedtronic plcFollow MDT — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 122.0B
P/E TTM: 23.4
Dividend yield: 3.0%
52-week: —
Next earnings: 16 Nov, in 23 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
1 Sep 26	Raised	FY27 organic revenue growth guidance raised to 7.25-7.75% from 6.75-7.25%; FY27 non-GAAP EPS guidance raised to $5.94-6.00 from $5.90-6.00.
3 Jun 26	Raised	Q4 revenue beat implied guidance by 90bps; non-GAAP EPS beat guidance
17 Feb 26	Reaffirmed	FY26 organic revenue growth ~5.5%, non-GAAP EPS $5.62-$5.66 · full year
18 Nov 25	Raised	Organic revenue growth raised to ~5.5% from ~5.0%; EPS raised to $5.62-$5.66 from $5.60-$5.66 · full year
19 Aug 25	Raised	FY26 non-GAAP EPS guidance raised to $5.60-$5.66 from $5.50-$5.60 · full year

Medtronic plc — questions

What guidance did Medtronic plc give?: On 2026-09-01: "FY27 organic revenue growth guidance raised to 7.25-7.75% from 6.75-7.25%; FY27 non-GAAP EPS guidance raised to $5.94-6.00 from $5.90-6.00."
When does Medtronic plc report earnings?: Medtronic plc's next earnings report is expected on 2026-11-16.

Every figure on this page comes from Medtronic plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.